With passion for patients and science, the Marinomed team is proud of its track record of successful product and drug development in respiratory, infectious, immunological, and ophthalmic diseases. As it is our ambition to transform the lives of patients, we seek to work with strategic partners that join us on this journey.
Our team is advancing our development portfolio leveraging our deep scientific expertise in immunology and virology. We foster collaboration with our international network of scientists, key opinion leaders, academic institutions, and development partners to develop creative paths to bring our treatments to the patients in need. We are committed to long-term relationships and strategic alliances with the opportunity for shared success.
Areas of interest
Marinomed is constantly looking for strong mutually beneficial partnerships. We are interested in cooperation with pharmaceutical companies in the following areas:
- Our pipeline: to maximize the potential of our internal assets we actively seek partners to accelerate the development and commercialization of our existing pipeline.
- Carragelose®: Marinomed has been successfully represented on the market for several years with its existing portfolio of OTC products to treat cold viruses. Currently, we collaborate with 17 commercialization partners for more than 40 countries and are interested in further expansion of our distribution network. Marinomed is also expanding its Carragelose® portfolio with an allergy-blocking nasal spray and moisturizing eye drops which are both available for partnerships.
- Solv4U: To address solubility and bioavailability issues and to support formulation development of Active Pharmaceutical Ingredients (APIs) we offer technological partnerships in all stages of drug discovery based on our proprietary innovative Marinosolv® technology platform.